Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stuart-Harris

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1991
Epirubicin: a phase II study in recurrent small-cell lung cancerM Rosenthal, R Kefford, D Raghavan, et al.
Breast (Edinburgh, Scotland)|May 6, 2008
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patientsR Stuart-Harris, C Caldas, S E Pinder, et al.
The Medical Journal of Australia|March 6, 1989
Health-care interpreters and cancerD Gorman, R Stuart-Harris, A O Langlands, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancerI E Smith, R Stuart-Harris, N Pavlidis, et al.
Breast (Edinburgh, Scotland)|October 20, 2009
The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomised phase III trials of aromatase inhibitorsR Stuart-Harris, B Shadbolt, C Palmqvist, et al.
British Journal of Cancer|December 1, 1990
Identifying priorities of psychosocial need in cancer patientsL P Liang, S M Dunn, A Gorman, et al.
British Journal of Cancer|October 1, 1986
Role of aminoglutethimide in male breast cancerA L Harris, M Dowsett, R Stuart-Harris, et al.
Cancer Treatment Reviews|September 1, 1983
High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcomaR Stuart-Harris, P G Harper, S B Kaye, et al.
Lancet (London, England)|July 28, 1984
Cardiotoxicity associated with mitoxantroneR Stuart-Harris, M Pearson, I E Smith, et al.
The Medical Journal of Australia|February 15, 1988
The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of AustraliaK Cox, R Stuart-Harris, G Abdini, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1991
Epirubicin: a phase II study in recurrent small-cell lung cancerM Rosenthal, R Kefford, D Raghavan, et al.
Breast (Edinburgh, Scotland)|May 6, 2008
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patientsR Stuart-Harris, C Caldas, S E Pinder, et al.
The Medical Journal of Australia|March 6, 1989
Health-care interpreters and cancerD Gorman, R Stuart-Harris, A O Langlands, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancerI E Smith, R Stuart-Harris, N Pavlidis, et al.
Breast (Edinburgh, Scotland)|October 20, 2009
The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomised phase III trials of aromatase inhibitorsR Stuart-Harris, B Shadbolt, C Palmqvist, et al.
British Journal of Cancer|December 1, 1990
Identifying priorities of psychosocial need in cancer patientsL P Liang, S M Dunn, A Gorman, et al.
British Journal of Cancer|October 1, 1986
Role of aminoglutethimide in male breast cancerA L Harris, M Dowsett, R Stuart-Harris, et al.
Cancer Treatment Reviews|September 1, 1983
High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcomaR Stuart-Harris, P G Harper, S B Kaye, et al.
Lancet (London, England)|July 28, 1984
Cardiotoxicity associated with mitoxantroneR Stuart-Harris, M Pearson, I E Smith, et al.
The Medical Journal of Australia|February 15, 1988
The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of AustraliaK Cox, R Stuart-Harris, G Abdini, et al.
Pageof 6